source
- Novo names former Galderma exec as new CFO as eight-year finance chief departs; Alnylam and Amgen also seek senior replacementsNovo's chief financial officer, who has served for eight years, will step down at the end of the year. The company has selected an executive from Galderma to take over the CFO role, signaling a le…
- One in Five Biopharma Workers Have Been Laid Off Multiple Times, Survey ShowsA recent BioSpace LinkedIn poll found that 64% of biotech and pharma professionals have been laid off in the past five years, and 22% have experienced job loss at least twice. Those who have faced…